A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Trial Details

NCT ID

NCT07115043

Phase

PHASE1 / PHASE2

Sponsor

AstraZeneca

Status

RECRUITING

Cancer Type

Non-Small Cell (NSCLC) Lung Cancer

Interventions

• AZD6750
• rilvegostomig

Locations (sample)

• Grand Rapids, Michigan, United States|42.96336,-85.66809
• St Louis, Missouri, United States|38.62727,-90.19789
• Pittsburgh, Pennsylvania, United States|40.44062,-79.99589
• Houston, Texas, United States|29.76328,-95.36327
• San Antonio, Texas, United States|29.42412,-98.49363

Key Eligibility Criteria

• Participant ≥ 18 year
• ECOG PS of 0 to 1
• Provision of 'archival' tumor specimen
• At least one measurable lesion according to RECIST v1.1,

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.